Malvern, PA, United States of America

Q Jean Zhou

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Adolor Corporation. Active years: 2007-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Q Jean Zhou. Retrieved from https://idiyas.com/inventor/q-jean-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Q Jean Zhou: Innovator in Pharmaceutical Compounds

Introduction

Q Jean Zhou is a notable inventor based in Malvern, PA (US), recognized for his contributions to the field of pharmaceutical compounds. He holds 2 patents that focus on novel chemical compounds with potential therapeutic applications. His work is significant in addressing various medical conditions through innovative chemical solutions.

Latest Patents

One of Zhou's latest patents is centered around phenyl derivatives and methods of use. This patent discloses novel phenyl compounds, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use. The compounds are designed to act as agonists and/or ligands of cannabinoid receptors, which may be beneficial in treating and/or preventing pain, gastrointestinal disorders, genitourinary disorders, inflammation, glaucoma, auto-immune diseases, ischemic conditions, immune-related disorders, and neurodegenerative diseases. Additionally, these compounds may provide cardioprotection against ischemic and reperfusion effects, induce apoptosis in malignant cells, and serve as appetite stimulants.

Another significant patent by Zhou involves sulfamoyl benzamide derivatives and methods of their use. This patent reveals novel sulfamoyl benzamide compounds, pharmaceutical compositions containing these compounds, and their pharmaceutical applications. Similar to his phenyl derivatives, these compounds are also agonists and/or modulating ligands of cannabinoid receptors. They may be useful in treating and/or preventing a range of conditions, including pain, gastrointestinal disorders, inflammation, auto-immune diseases, ischemic conditions, immune-related disorders, hypertension, neurological disorders, and neurodegenerative diseases. These compounds also have potential applications in providing cardioprotection, inducing apoptosis in malignant cells, and inhibiting mechanical hyperalgesia associated with nerve injury.

Career Highlights

Q Jean Zhou is currently associated with Adolor Corporation, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Zhou collaborates with notable colleagues, including Roland Ellwood Dolle and Karin Worm, who contribute to his research and development efforts.

Conclusion

Q Jean Zhou's innovative work in pharmaceutical compounds showcases his commitment to advancing medical science through novel chemical solutions. His patents reflect significant potential in treating various health conditions, underscoring his role as a key inventor in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…